Volume 87, Number 5
Aspirin for primary prevention of atherosclerotic cardiovascular events
How to Obtain AMA PRA Category 1 Credit™ and ABA, ABIM, ABP, ABPath, ABS MOC points
- Review information on this page.
- Read the journal article.
- Return to this page to advance to claim CME or MOC.
- Login to your myCME account.
- If claiming MOC, choose the 'CME & MOC' option and complete the posttest.
- Complete the registration / evaluation form.
- Print your personalized CME / MOC certificate.
Release Date: May 1, 2020
Expiration Date: April 30, 2021
Estimated Time of Completion: 1 hour
Description
A more limited role for aspirin as primary prevention in patients at intermediate risk, with diabetes, and the elderly.
Disclosures
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they have a relationship which, in the context of their contributions, could be perceived as a potential conflict of interest:
Brian F. Mandell, MD, PhD (Activity Director) | ||
Consulting, Teaching, Speaking | Genentech | |
Consulting | Horizon Pharma | |
Consulting, Advisory committee, Review panels | Takeda Pharmaceutical Ltd. | |
Christian Nasr, MD | ||
Advisory committee, Review panels | Exelixis, Nevro Corporation | |
Bernard Silver, MD | ||
Board membership | Takeda |
All other authors, co-activity directors, reviewers and CCJM staff report no relevant financial relationships which, in the context of their contributions, could be perceived as a potential conflict of interest.
(Article opens in a new tab / window; return to this window to complete the activity).
This CME activity was produced by the Cleveland Clinic Journal of Medicine and the Cleveland Clinic Center for Continuing Education.